Luminescent detection of DNA-binding proteins by Chan, DSH et al.
Title Luminescent detection of DNA-binding proteins
Author(s) Leung, CH; Chan, DSH; He, HZ; Cheng, Z; Yang, H; Ma, DL
Citation Nucleic Acids Research, 2012, v. 40 n. 3, p. 941-955
Issued Date 2012
URL http://hdl.handle.net/10722/168642
Rights This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
SURVEY AND SUMMARY
Luminescent detection of DNA-binding proteins
Chung-Hang Leung1,*, Daniel Shiu-Hin Chan2, Hong-Zhang He2, Zhen Cheng2,
Hui Yang2 and Dik-Lung Ma2,*
1Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao (China) and 2Department of
Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong (China)
Received June 15, 2011; Revised August 31, 2011; Accepted September 1, 2011
ABSTRACT
Transcription factors play a central role in cell de-
velopment, differentiation and growth in biological
systems due to their ability to regulate gene expres-
sion by binding to specific DNA sequences within
the nucleus. The dysregulation of transcription
factor signaling has been implicated in the patho-
genesis of a number of cancers, developmental dis-
orders, inflammation and autoimmunity. There is thus
a high demand for convenient high-throughput
methodologies able to detect sequence-specific
DNA-binding proteins and monitor their DNA-
binding activities. Traditional approaches for protein
detection include gel mobility shift assays, DNA
footprinting and enzyme-linked immunosorbent
assays (ELISAs) which tend to be tedious, time-
consuming, and may necessitate the use of
radiographic labeling. By contrast, luminescence
technologies offer the potential for rapid, sensitive
and low-cost detection that are amenable to high-
throughput and real-time analysis. The discoveries
of molecular beacons and aptamers have spear-
headed the development of new luminescent
methodologies for the detection of proteins over
the last decade. We survey here recent advances
in the development of luminescent detection
methods for DNA-binding proteins, including those
based on molecular beacons, aptamer beacons,
label-free techniques and exonuclease protection.
INTRODUCTION
Many proteins are involved in regulating cellular pro-
cesses through their ability to bind and interact with
DNA. Transcription activators or repressors regulate
gene expression by binding to speciﬁc DNA sequences
within the regulatory regions of genes (1). Due to their
important role in the regulation of the gene expression,
transcription factors play a central role in cell develop-
ment, differentiation and growth in biological systems
(2–4). Transcription factors typically exist in the cell in
an inactive state, and become activated by the presence
of a speciﬁc ligand, leading to the expression of target
gene(s). The inhibition or undesired activation of transcrip-
tion factors can lead to a number of diseases including
cancer, developmental disorders, abnormal hormone re-
sponses, autoimmunity and inﬂammation (5–10). The
cellular levels of such proteins can thus be used as diag-
nostic markers for many diseases, and the targeting of
transcription factor activity represents a potential avenue
for therapeutic intervention (11–13). Therefore, rapid and
convenient high-throughput methodologies to detect
sequence-speciﬁc DNA-binding proteins and monitor their
DNA-binding activities are in high demand. Such
technologies may be used for the development of inhibi-
tors for the diagnosis or treatment of diseases related to
dysfunctional transcription factor activity.
Traditional approaches for protein detection include gel
mobility shift assays (5), DNA footprinting (6) and
enzyme-linked immunosorbent assays (ELISAs) (7). In
the gel mobility shift assays, the protein-bound and free
DNA species are separated in non-denaturing polyacryl-
amide or agarose gel, and usually employ radioisotopes for
visualization. These assays thus tend to be time-consuming,
tedious and necessitate stringent safety measures to control
radiographic exposure. Several DNA footprinting methods
have been introduced including DNase I, exonuclease III,
methidiumpropyl-EDTA-Fe(II),
1,10-phenanthroline-Cu(I) and EDTA-Fe(II) footprinting
(6,8–10). Complementary approaches based on disrupting
binding (interference footprinting) by speciﬁc base or
phosphate modiﬁcations have also been developed (11).
Gel mobility shift assays and DNA footprinting methods
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provide information on the highest afﬁnity sites within a
segment of DNA, but they do not provide quantitative
binding information. ELISAs (7) are more sensitive and
offer higher throughput detection, but they require
multiple preparation and signal-ampliﬁcation steps for
the detection of low abundance transcription factors.
Additionally, none of the traditional methods are
amenable for real-time analysis.
Luminescence-based methodologies have emerged as an
attractive alternative to the traditional methods of tran-
scription factor activity detection due to their simplicity,
low cost, high sensitivity and amenability to
high-throughput screening (12). The use of luminescence
also negates concerns related to radiographic exposure
and/or the disposal of radioactive waste. The selectivity
of luminescence detection can be easily achieved through
modulation of the excitation and emission wavelengths. In
addition, luminescence provides a rapid and continuous
signal, allowing real-time monitoring of processes and
cellular imaging by microscopy.
Over the last decade, there have been extraordinary
advances in the ﬁeld of luminescent methodologies for
the detection of DNA-binding proteins. The discovery of
molecular beacons (MBs) and aptamers have spurred the
development of novel sensing platforms based on the
myriad of DNA topologies and luminescent dyes available
for the construction of the nucleic acid probe. We survey
here recent advances in the development of luminescent
methods for sensing DNA-binding proteins. For ease of
access, we have divided the survey into several categories:
(i) early methods (pre-2000) based on ﬂuorescence
anistropy or rudimentary FRET methods; (ii) the MB
strategy; (iii) the use of aptamers for protein detection,
including aptamer beacons; (iv) label-free detection of
proteins using MBs or aptamers; and (v) methods based
on exonuclease protection. We give a brief description for
each assay and summarize their main ﬁndings, and we
evaluate the advantages and disadvantages of each tech-
nique particularly with regards to sensitivity, selectivity,
robustness and generalizability.
EARLY METHODS FOR LUMINESCENT PROTEIN
DETECTION
The ﬁrst methods for the luminescent detection of DNA-
binding proteins were based on the recognition of the
cognate sequence by the transcription factor, resulting in
a change in the ﬂuorescent properties of the labeled oligo-
nucleotide or protein. As these methods are not the focus
of our survey, we highlight here only a few examples of the
early DNA-binding protein assays before they were sup-
erseded by the more modern FRET techniques discussed
later. In 1990, Heyduk and Lee developed a novel ﬂuor-
escence method to study the binding of Escherichia coli
cAMP receptor protein (CRP) to the lac promoter (13).
CRP, also known as catabolite gene activator protein
(CAP), is a cAMP-binding regulatory protein in bacteria
(14–16). A 32-bp duplex fragment 50-CGCAATTAATGT
GAGTTAGCTCACTCATTAGG-30 of the lac promoter
containing the primary binding site for CRP was labeled
with 7-diethylamino-3-(40-maleimidylphenyl)-4-methyl-
coumarin (CPM) at the 50-end via a short thiol linker.
The cAMP-mediated binding of CRP to this duplex
fragment can be followed by ﬂuorescence anisotropy or
ﬂuorescence resonance energy transfer (FRET) from the
protein tryptophan residues to CPM. The ﬂuorescence
titration results showed that a linear increase in the an-
isotropy or ﬂuorescence intensity was observed with
increasing CRP/DNA ratio in the presence of cAMP
until 1.0, after which both signals plateaued. However,
the maximal fold-change in the ﬂuorescence emission
response was only 20%, presumably due to unoptimized
nature of the FRET interaction between the tryptophan
residues and CPM. No detection limit was reported in the
paper, but the data presented showed an observable in-
crease in the ﬂuorescence emission at CRP/DNA=0.2,
corresponding to 20 nM of CRP (13).
A FRET approach was employed by Parkhurst and
co-workers in 1996 to study the interaction of
Saccharomyces cerevisiae TATA-binding protein (TBP)
with the TATA-promoter element (17). A 14-bp
50-GGGCTATAAAAGGG-30 based on the adenovirus
major late promoter was doubly labeled with tetramethyl-
rhodamine (TMR) and ﬂuorescein at the 50- and
30-termini, respectively. In the absence of TBP, the rela-
tively rigid nature of the DNA duplex holds the ﬂuoro-
phores apart, resulting in a low FRET response. However,
addition of TBP bends the DNA and brings the 30- and
50-ends of the duplex closer together, resulting in a 37%
decrease in the emission at 520 nm of ﬂuorescein (donor)
at a saturating 14:1 ratio of protein: DNA. FRET to the
rhodamine (acceptor) moiety resulted in a concomitant
increase in the emission at 580 nm. While not described
as such, this early approach could be considered a proto-
type of the MB strategy.
In 1997, Gorski and co-workers (18) utilized ﬂuores-
cence anisotropy to investigate the binding of estrogen re-
sponse element (ERE) sequences to the estrogen receptor
(ER) (19). A 35-bp duplex sequence 50-AGCTTCGAGGA
GGTCACAGTGACCTGGAGCGGATC-30 containing
the palindromic chicken vitellogenin ERE (20) was labeled
with ﬂuorescein at the 50-end. Interestingly, both estradiol-
bound and unbound ER was found to interact with the
consensus ERE sequence with similar afﬁnity, indicating
that estrogen affects ER activity at a step other than DNA
binding. However, at saturation, the ﬂuorescence anisot-
ropy of the DNA label increased by only 15%. While no
detection limit was reported by the authors, the data
suggest that 1 nM of ER could be readily detected by
the ﬂuorescence anisotropy method (18).
Even up until 2000, ﬂuorescence anistropy was still
being utilized for analysis of protein–DNA interactions,
such as the interactions of herpes simplex virus type I
protein (21) or human papillomavirus E2 protein (22)
with DNA. The chief advantage of ﬂuorescence anistropy
methods is that only one ﬂuorescent label on the DNA is
required. However, ﬂuorescence polarization is generally
limited by a small dynamic range and is strongly depend-
ent on the sizes of the DNA and protein molecules.
Additionally, ﬂuorescence anistropy is unable to give a
visual signal, and this limits the applicability of such
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methods for the optical detection of DNA-binding
proteins. Consequently, the use of ﬂuorescence anistropy
for protein detection has fallen somewhat out of favor,
and its current primary use is for the direct measurement
of binding isotherms for protein–DNA interactions (23).
In the work by Heyduk and Lee (13), a change in the
emission of the ﬂuorophore results from resonance energy
transfer between endogenous tryptophan residues in the
protein to the ﬂuorescent label on the oligonucleotide. The
intensity of the ﬂuorescence signal thus depends on several
factors, such as the number of tryptophan residues in the
protein as well as their proximity to the DNA-binding site
in the protein. This method therefore is not generally
applicable for the detection of DNA-binding proteins.
Interest in these early methods for the detection of
DNA-binding proteins waned soon after the emergence
of MBs, as described in the next section.
METHODS FOR PROTEIN DETECTION USING
MOLECULAR BEACONS
MBs have been widely used for the detection of nucleic
acids due to their strong afﬁnity and selectivity for their
complementary sequences (24–26). The classical MB
approach employs a DNA hairpin (stem-loop) oligo-
nucleotide doubly-labeled with a ﬂuorophore and a
quencher at its two termini. In solution, the oligonucleo-
tide exists in a hairpin conformation and is weakly ﬂuor-
escent in solution due to effective FRET. Addition of the
target DNA sequence ‘opens up’ the MB through hybrid-
ization, forming a duplex structure releases the ﬂuoro-
phore resulting in the restoration of ﬂuorescence
emission. Alternatively, if a ﬂuorescent acceptor is used
in place of a quencher, the emission of the acceptor label
can also be measured to monitor the target-binding event.
Various combinations of ﬂuorescent labels and nucleic
acid conformations have been employed to develop a
range of switch-on or switch-off luminescent MBs for
DNA-binding proteins.
One of the ﬁrst approaches employing the MB for the
detection of DNA-binding proteins was reported by Tan
and co-workers in 2000 (27). A 29-bp DNA sequence 50-G
CTCGTCCATACCCAAGAAGGAAGCGAGC-30 was
labeled with tamra (TMR) and dabcyl [4-(40-dimethyl-
aminophenylazo)benzoic acid] at the 50- and 30-termini,
respectively. This oligonucleotide was utilized to detect
the presence of E. coli single-stranded DNA-binding
protein (SSB) (28). The binding of SSB to the MB was
expected to disrupt the hairpin conformation of the oligo-
nucleotide, resulting in the release of the ﬂuorophore and
the restoration of ﬂuorescence (Figure 1a). Fluorescence
titration experiments with SSB indicated a 1:1 binding
ratio of the protein to the DNA, and a maximum
fold-change of 30-fold was reached at 2:1 ratio. The
detection limit for SSB for this system was determined to
be 0.2 nM (27). This pivotal work by Tan and co-workers
demonstrated that the MB approach could be successfully
utilized for the switch-on detection of SSB with high sen-
sitivity and selectivity (27). However, this system would be
unable to differentiate between different SSB due to the
lack of sequence recognition involved in the target-binding
event. Later, the group utilized a similar MB strategy to
analyze the non-speciﬁc binding of lactate dehydrogenase
to single-stranded (ss) DNA (29).
In 2002, Heyduk and Heyduk developed a general strat-
egy for the detection of sequence-speciﬁc DNA-binding
proteins (30). In this variation of aMB approach, the bind-
ing sequence for the transcription factor was split into two
half-sites distributed between two labeled duplex frag-
ments containing partially complementary overhangs.
The sequence-speciﬁc binding of the transcription factor
drives the formation of the DNA duplex, bringing the
ﬂuorochromes into close proximity and resulting in a
high FRET signal (Figure 1b). For the detection of
CAP, a 38-bp sequence corresponding to the consensus
CAP site was used to generate the two half-site duplexes,
each containing a 6-nt overhang of which only two were
complementary to the other strand. The presence of CAP
promoted the association of the two half-site duplexes,
causing the emission of ﬂuorescein (ﬂuorophore) to be
quenched by dabcyl (quencher). A maximum quenching
efﬁciency of 70% was reached at 3:1 ratio of the CAP to
the half-site duplexes (used at 50 nM). While no detection
limit for this switch-off assay was reported by the authors,
the data showed that nanomolar CAP could be readily
detected (30). To achieve a switch-on ﬂuorescence detec-
tion mode, Heyduk and Heyduk employed coumarin as a
ﬂuorescence donor and ﬂuorescein as the acceptor. An
3-fold increase in the acceptor: donor emission ratio
was observed at a saturating level of the protein. While
the fold-change increase of this system was modest, the
ratiometric detection of the signal could potentially miti-
gate the effects of a high background and/or non-selective
quenching mechanisms due to interfering substances in the
solution. The authors also adapted the MB for other pro-
karyotic transcription factors including trp repressor and
lac repressor, and the human cancer-related DNA-binding
protein p53, and for the detection of p53 in HeLa nuclear
cell extracts. Furthermore, this MB approach was demon-
strated for the multiplex detection of DNA-binding
proteins. This important work by Heyduk and Heyduk
demonstrated the feasibility of this alternative MB
strategy as a general method for the selective detection
of DNA-binding proteins (30). However, one drawback
to this approach was that the rate of association of the
half-site duplexes was relatively slow. Kinetic analysis per-
formed by the group in a later work suggested that the
rate of association of the duplex half-sites was the
rate-limiting step of the overall reaction (31).
Heyduk and co-workers later developed a variant of the
MB approach for CAP detection by tethering the two
half-site duplexes together with a polyethylene glycol
linker (32). The rationale for developing the unimolecular
beacon was that the response time of the assay could be
improved by enhancing the association of the two frag-
ments, the rate-limiting step of the overall reaction (31). In
this study, the addition of the target would be expected to
convert the beacon from an ‘open’ formation to the
‘closed’ state, resulting in quenching of ﬂuorescein by
dabcyl (Figure 1c). When the protein was rapidly mixed
with the MB, stopped-ﬂow ﬂuorescence measurements
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revealed that the reaction was complete in 0.5 s, which
was 1200-fold faster than that with the bimolecular
beacon (10min) (30), verifying the authors’ hypothesis.
60% quenching was observed at a saturating concentra-
tion of CAP, and the data indicated a nanomolar detec-
tion limit. The authors also demonstrated the application
of the unimolecular MB for immobilization onto a solid
support, which opens up possibilities for the high-
throughput detection of multiple protein targets. The
immobilized MB was also able to sense nanomolar
thrombin with a similar performance compared to the
free beacon (32).
The chief advantages of MBs over the ﬂuorescence
polarization and early FRET methods described in the
previous section are increased dynamic range and inde-
pendence of the ﬂuorescent signal to the size of the mol-
ecules or number and position of endogenous ﬂuorescent
amino acid residues, respectively. As a result, the MB can
be readily adapted for sensing different DNA-binding
proteins simply by changing the binding sequence of the
oligonucleotide. However, these methods are still limited
to the detection of proteins with intrinsic DNA-binding
activity. The development of nucleic acid aptamers has
extended the range of protein targets that can be detected,
as discussed below.
METHODS FOR PROTEIN DETECTION USING
APTAMERS
Aptamers can be regarded the nucleic acid equivalents of
protein antibodies, and both DNA and RNA aptamers
have been developed for a range of different targets in-
cluding organic dyes, nucleotides, biological cofactors,
amino acids, peptides and enzymes (33,34). These
aptamers have been generally developed by the systematic
evolution of ligands by exponential enrichment (SELEX)
(35–38), a selection process that allows the discovery of
high afﬁnity ligands for any chemical or biological target.
Compared to protein antibodies, DNA aptamers are gen-
erally smaller, less expensive to manufacture and modify,
stable over a greater range of temperatures and pH values,
and more readily reusable. Also, while the ﬂuorescence
signal of ﬂuorescently-labeled antibodies generally remains
the same whether or not the antibody is bound to the
Figure 1. (a) Schematic representation of the MB strategy for the switch-on detection of prokaryotic ssDNA binding protein via the target-induced
conversion of the MB hairpin into an ss conformation (27). (b) Schematic representation of MB strategy for the switch-on detection of prokaryotic
CAP via the target-promoted association of the half-site duplexes (30). (c) Schematic representation of the unimolecular beacon strategy for the
switch-off detection of thrombin via the target-induced formation of the closed state (31).
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protein, the ligand-mediated transition of the aptamer sec-
ondary structure can be conveniently monitored using
covalently-attached luminescent labels or non-covalent lu-
minescent probes. These promising features of DNA
aptamers have made them highly useful for sensing and
biotechnology applications (39–44).
One of the ﬁrst methods employing aptamers for the
detection of nucleic acid-binding proteins was reported
by Kumar and co-workers in 2000 (45). The HIV Tat
protein RNA aptamer RNATat (46) was split into two
separate strands, and one of the oligomers was elaborated
into a MB by extending the sequences ﬂanking the binding
site with complementary nucleotides that was labeled with
ﬂuorescein and dabsyl at the 50- and 30-termini, respective-
ly. Thus, the MB 50-CGCGAAGCUUGAUCCCGAGA
GCUUA-30 (termed F-BA1-D) forms a stem–loop struc-
ture in solution with the binding residues located in the
loop of the hairpin. Due to only partial complementarity
of the beacon with the other half of the RNA aptamer
50-CUCGGUCGAUCGCUUC-30 (termed DA-2), the
RNA duplex is not formed in the absence of Tat and
the ﬂuorescence of system remains low. The addition of
the protein target causes the dissociation of the hairpin
and promotes the formation of the Tat: F-BA1-D: DA-2
ternary complex, releasing the ﬂuorophore and resulting
in a switch-on ﬂuorescence enhancement (Figure 2). In the
presence of the minimal recognition region of Tat-1,
termed CQ peptide, the emission of ﬂuorescein was
increased by 4.9-fold at a 10:1 ratio of the peptide to the
beacon. Despite the relatively complex duplex nature of
the RNA aptamer, necessitating the formation of a
ternary complex with the protein target, this early work
by Kumar demonstrated that the aptamer concept could
be successfully utilized in conjunction with MBs to engin-
eer novel oligonucleotide-based sensing platforms for
nucleic-acid binding proteins.
Hamaguchi and co-workers (47) designed a MB for
thrombin (48) detection based on the thrombin aptamer
in 2001. Intriguingly, the guanine-rich thrombin aptamer
50-GGTTGGTGTGGTTGG-30 (termed G15D) binds
thrombin in an antiparallel G-quadruplex conformation
(49,50). The aptamer was converted into a MB by extend-
ing the 50-end of the aptamer by 5 nt, such that a hairpin
conformation would be favoured in the absence of the
target, and the aptamer beacon 50-CCAACGGTTGGTG
TGGTTGG-30 (G15D5d) was labeled with ﬂuorescein and
dabcyl at the 50- and 30-ends, respectively (Figure 3a).
Since thrombin only binds to the G-quadruplex conform-
ation, addition of the target shifts the equilibrium towards
the quadruplex form, resulting in the restoration of ﬂuor-
escence. A maximum 2.5-fold increase in the ﬂuorescence
emission intensity was recorded at a saturating concentra-
tion of thrombin (45). No detection limit was reported by
the authors, but 10 nM of thrombin could be readily
detected using this assay. This early work by Hamaguchi
demonstrated the application of molecular aptamer bea-
cons for the detection of thrombin detection, and showed
that the design of the molecular aptamer beacon was very
important for the assay principle due to the strong de-
pendence of the duplex–quadruplex equilibrium on the
nucleotide sequence (45).
Tan and co-workers developed an alternative molecular
aptamer beacon strategy for thrombin detection in 2002
(51). The 17-nt thrombin aptamer sequence 50-TGGTTG
GTGTGGTTGGT-30 was labeled according to quenching
or FRET detection modes. In this approach, the molecu-
lar aptamer initially exists as a random coil conformation,
in which the ﬂuorochromes are far apart (Figure 3b). The
addition of the target protein shifts this equilibrium
towards the G-quadruplex, resulting in quenching or an
increase in acceptor emission for the quenching and FRET
detection modes, respectively. For the quenching mode, a
60% decrease in the emission of ﬂuorescein was observed
at a saturating concentration of thrombin, and a detection
limit of 0.37 nM of thrombin was reported (51). For the
FRET mode of detection, the addition of thrombin
resulted in 1-fold increase in the ﬂuorescence intensity
of ﬂuorescein upon excitation of coumarin, with a detec-
tion limit of 0.43 nM. The performance of the sensor could
be improved by ratiometric analysis of the acceptor and
donor emission intensities. With ratiometric measurement,
the detection limit was lowered to 0.11 nM (51).
Li and co-workers designed a general aptamer beacon
method for the detection of small molecules and proteins
based on the target-induced disruption of a MB duplex
(52). Unlike previous approaches, this strategy is less de-
pendent on the size and structure of the aptamer. In the
present study, the aptamer beacon consists of a tripartite
duplex structure consisting of a 50-ﬂuorescein-labeled
oligomer (FDNA), a 30-dabcyl-labeled oligomer
(QDNA) and a longer oligonucleotide sequence compris-
ing Stem-1 and Stem-2 that are complementary to FDNA
and QDNA, respectively. Stem-2 also contains the
thrombin binding sequence 50-GGTTGGTGTGGTTGG
-30 in a partial overhang. The addition of thrombin
promotes the formation of the aptamer-target complex,
leading to the dissociation of QDNA and the release of
the ﬂuorescein ﬂuorophore, resulting in a ﬂuorescence en-
hancement (Figure 4a). Titration experiments with
thrombin revealed a linear response to thrombin concen-
trations over the range of 10–1000 nM with a maximum
Figure 2. Schematic representation of molecular aptamer beacon strat-
egy for the switch-on detection of viral Tat protein via the target-
induced conversion of the MB hairpin into the aptamer duplex (45).
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12-fold enhancement in the ﬂuorescence intensity (52).
Although no detection limit was reported, 10 nM of
thrombin could be readily sensed using this assay.
Interestingly, reducing the number of blocked nucleotides
in the aptamer sequence by QDNA also improved the per-
formance of the ATP aptamer beacon reported in
the same work, as this promotes the formation of the
aptamer–target complex (52).
In 2005, Heyduk and co-workers developed a molecular
aptamer beacon strategy for the detection of thrombin
based on the protein-induced co-association of two
aptamers recognizing distinct epitopes of the protein
Figure 3. (a) Schematic representation of the molecular aptamer beacon strategy for the switch-on detection of thrombin via the target-induced
conversion of the MB hairpin into the G-quadruplex aptamer (45). (b) Schematic representation of the molecular aptamer beacon strategy for the
switch-on (FRET) or switch-off (quenching) detection of thrombin via the target-induced conversion of the random coil into the G-quadruplex
aptamer (51).
Figure 4. (a) Schematic representation of the structure-switching aptamer strategy for the switch-on detection of thrombin via the target-induced
dissociation of the duplex structure (52). (b) Schematic representation of molecular aptamer beacon design for the switch-on (FRET) or switch-off
(quenching) detection of thrombin based on the target-induced co-association of two distinct aptamer recognizing distinct epitopes (53). (c) Schematic
representation of aptamer beacon design for the excimer-based detection of PDGF via the target-induced hybridization of the terminal arms (54).
(d) Schematic representation of the polyethylene glycol-linked aptamer beacon strategy for the switch-on detection of thrombin via the target-induced
dissociation of the duplex conformation (58).
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(53). The 60–18 50-AGTCCGTGGTAGGGCAGGTTGG
GGTGACT-30 aptamer recognizing the ﬁbrinogen-
binding exosite was labeled with ﬂuorescein at the 50-end
while the G15D aptamer recognizing the heparin-binding
site was labeled with dabcyl at the 30-terminus. The
ﬂuorophores were connected to their respective aptamers
via a polyethylene glycol linker and a 7-nt complementary
sequence, allowing the hybridization of the aptamers when
both are bound to the target and resulting in efﬁcient
FRET (Figure 4b). A maximum quenching of 40%
was observed at a saturating concentration of thrombin,
with a detection limit of 1 nM of thrombin (53). With
FRET ﬂuorophores, up to 15-fold enhancement in the
ﬂuorescent emission of the acceptor could be observed,
greatly improving the dynamic range of the sensor and
allowing a favorable switch-on mode of detection. A
further modiﬁcation could be made by employing a
europium chelate-Cy5 pair, which allows for a time-
resolved FRET (TR-FRET) detection mode. In TR-
FRET, the effects of background due to light scattering
are avoided, allowing a further improvement of the
signal-to-noise ratio of the beacon. With the Eu3+-Cy5
pair, a maximum 22-fold change in the ﬂuorescence
signal was registered. Additionally, an improved detection
limit of 50 pM for thrombin was achieved (53). One ad-
vantage of this method over previously reported assays
utilizing a single aptamer beacon is that the co-association
of three molecular ‘contacts’ is required to generate a
ﬂuorescence signal. Due to the exponential relationship
between the free energy and equilibrium dissociation con-
stant of the complex, the overall stability of the complex
will be greatly decreased if any of the three components
were absent. Thus, the dual aptamer MB exhibited a
greater speciﬁcity for thrombin detection compared to
the single aptamer beacons. The authors also demon-
strated that the dual aptamer beacon could detection
nanomolar thrombin in spiked HeLa cellular extract and
in factor Xa-treated plasma.
In 2005, the group of Turro and Tan (54) reported a
molecular aptamer beacon for the detection of platelet-
derived growth factor (PDGF)-BB (55,56) based on
pyrene excimer emission. In the absence of protein, the
PDGF-BB aptamer assumes a partial duplex structure
where the 50- and 30-ends of the aptamer are free in
solution. The binding of PDGF-BB promotes the hybrid-
ization of the terminal strands, forming a three-helix
junction (Figure 4c). Where the ends of the aptamer are
labeled with pyrene units, this causes a change of the ﬂuor-
escence proﬁle of pyrene from monomer emission (two
signals at 375 and 398 nm) to excimer emission (485 nm)
due to the close proximity of an excited state molecule
with another ground state molecule. The 3-mer stem
aptamer 50-AGGCTACGGCACGTAGAGCATCACCA
TGATCCT-30 gave the maximal signal response of the
beacon to PDGF, 40-fold at saturation. The results
revealed a linear response to PDGF over the range 0–
40 nM, with a detection limit in the picomolar range
(54). The authors also investigated the application of the
excimer beacon for the detection of PDGF-BB in cell
media. Taking advantage of the very long ﬂuorescence
lifetime (100 ns) of the pyrene excimer compared to
most of the endogenous biological background ﬂuores-
cence species (<5 ns), time-resolved ﬂuorescence measure-
ments were used to improve the sensitivity of the probe for
PGDF in cell media, and a linear response to PDGF-BB
concentration was observed over the range of 0–100 nM in
cell media (54). As a proof-of-concept, the TNF-a-induced
stimulation of PDGF production in human prostate
cancer cells was readily detected using the excimer
beacon. Although this MB relies on the speciﬁc conform-
ation change of the PDGF aptamer and is not readily
generalizable to other proteins, the authors demonstrated
that the pyrene excimer emission can be a powerful tool
for the sensitivity detection of proteins in the presence of
interfering biological ﬂuorophores in cell media.
Katilius and co-workers developed a variation of the
molecular aptamer beacon strategy for the detection of
proteins by incorporation a ﬂuorescent nucleotide
anologs within the aptamer sequence (57). The ﬂuores-
cent quantum yields of these nucleotide anologs, such as
2-aminopurine (2AP), 4-amino-6-methylpteridone
(6MAP) or 3-methylisoxanthopterin (3MI), are strongly
dependent on the base-stacking interactions between the
anolog and its neighbors in the SS or duplex chain.
Consequently, if the ﬂuorescent nucleotide is incorporated
at a position that undergoes conformational change upon
aptamer binding, the binding event can be monitored by
measuring the emission signal of the nucleotide anolog.
According to the published structure of the thrombin–
aptamer complex, the thymine residue at position
7 becomes unstacked relative to its neighboring bases
upon formation of the G-quadruplex, where it occupies
part of a loop that does not interact with the protein.
Thus, the authors incorporated a ﬂuorescence nucleotide
at T7, and a maximal 30-fold increase in the ﬂuorescence
intensity of 6MAP was registered upon addition of a
saturating concentration of thrombin (57). While no de-
tection limit was reported by the authors, the data
revealed that 20 nM of thrombin could be readily de-
tected using the 6MAP-modiﬁed aptamer. With PDGF
and immunoglobulin E (IgE), no information on the
tertiary structure of the aptamer–protein complex was
available to the authors. However, the authors were able
to calculate the secondary structure of the aptamer using
the program mfold and predict which residues of the
oligonucleotide would undergo major conformational
changes upon target binding. The results showed that
6MAP modiﬁcation at position 22 of the PDGF
aptamer 50-CACAGGCTACGGCACGTAGAGCATCA
CCATGATCCTGTG-30 produced a 6.7-fold ﬂuorescence
increase upon saturating concentrations of the protein,
with a detection limit of 10 nM. For the aptamers
modiﬁed at the other positions, the addition of protein
produced either no change or a slight decrease. This dem-
onstrates that the actual position of the ﬂuorescent nu-
cleotide is of critical importance in the performance of
the modiﬁed aptamer for protein detection. Using
similar methods, replacement of position 18 of the IgE
aptamer 50-GGGGCACGTTTATCCGTCCCTCCTAG
TGGCGTGCCCC-30 with 2AP was found to give the
highest response to target binding, and a 5.6-fold
increase in the emission of the ﬂuorescent nucleotide was
Nucleic Acids Research, 2012, Vol. 40, No. 3 947
observed at a saturating concentration of IgE.
Interestingly, 6MAP exhibited the highest dynamic range
for the thrombin and PDGF aptamers, whereas 2AP gave
the highest fold change for the IgE aptamer (57). This
suggests that the ﬂuorescent nucleotides exhibit differen-
tial ﬂuorescent behavior upon target binding when
incorporated into the different aptamers, and that opti-
mization of the ﬂuorescent label can yield superior probe
performance.
In 2008, Tan and co-workers developed a variation of
the molecular aptamer beacon approach described previ-
ously (58). A polyethylene glycol linker was inserted into
the G15D5d thrombin aptamer to give an aptamer beacon
containing a longer loop region. The aptamer beacon 50-C
CAAC-(CH2CH2O)30-GGTTGGTGTGGTTGG-3
0 was
labeled with Chlorin e6 (Ce6) and Black Hole Quencher
2 (BHQ2) at the 50- and 30-ends of the oligomer, respect-
ively. In the absence of the protein, the aptamer beacon
forms a hairpin conformation containing a 5-mer stem
and the emission intensity of the ﬂuorophore is
quenched. The addition of thrombin promotes the dissoci-
ation of hairpin, releasing the ﬂuorophore and resulting in
a ﬂuorescence enhancement (Figure 4d). A 17.6-fold en-
hancement in ﬂuorescence was reported after the addition
of 300 nM of thrombin (58). Furthermore, the beacon was
selective for thrombin over IgG, IgM and BSA added at
the same concentration as thrombin. Mechanistically, the
molecular aptamer beacon for thrombin detection operates
in a similar fashion to that reported by Hamaguchi and
co-workers (47). The higher maximal signal response
reported in the present study may be attributed to the
long polyethylene glycol linker which holds the quencher
much further away from the aptamer strand upon target
binding, enhancing the ﬂuorescence intensity of the ‘on’
state. The use of the highly efﬁcient BHQ2 as the quencher
may also have contributed to the superior fold-change
response by lowering the background ﬂuorescence signal.
The authors also demonstrated the application of this
polyethylene glycol-linked aptamer beacon for ATP
detection.
In 2010, Yu and co-workers developed an interesting
aptamer probe for human neutrophil elastase (HNE)
using a three-component system (59). The HNE aptamer
50-TAGCGATACTGCGTGGGTTGGGGCGGGTAG
GGCCAGCAGTCTCGT-30 forms a G-quadruplex struc-
ture with duplex ends (60). The probe consists of the HNE
aptamer, a MB labeled with ﬂuorescein-dabcyl and an ss
that is complementary to both the aptamer and the bea-
con. In the absence of the target, the free aptamer forms a
duplex with ss, and the MB remains in the closed state
with a low ﬂuorescence. HNE competes with ss for the
DNA aptamer, and free ss is instead able to interact
with and open up the MB, resulting in the release of the
ﬂuorophore moiety and an enhancement of ﬂuorescence
emission (Figure 5). A linear response to HNE in the con-
centration range of 0.34–68 nM was observed, and a de-
tection limit of 47 pM was reported (59). The advantage of
this three-component system is that the aptamer does not
have to be ﬂuorescently labeled, so that the maximum af-
ﬁnity of the aptamer can be retained. Furthermore, this
system is readily generalizable to any protein–aptamer
pair as the precise structure of the aptamer is irrelevant
to the working principle of the assay.
LABEL-FREE METHODS FOR PROTEIN
DETECTION
MBs and molecular aptamer beacons tend to be relatively
easy to operate due the ﬁxed arrangement of the ﬂuoro-
phore moieties on the oligonucleotide. However, oligo-
nucleotide labeling is typically quite expensive, and can
comprise up to 90% of the total cost of the oligonucleo-
tide. Consequently, this has spurred the development of
‘label-free’ detection methods, where the luminescent
probe is not covalently bound to the oligonucleotide.
The key feature of label-free methods is that the emissive
properties of the luminescent probes are highly sensitive to
the local environment, such that the target-induced re-
arrangement of the MB or molecular aptamer beacon
can be readily transduced into a luminescent signal output.
Themuch lower cost of unlabeled oligonucleotides compared
to their ﬂuorescent counterparts makes them more attractive
for low-cost applications and/or high-throughput detection.
Figure 5. Schematic representation of the three-component aptamer strategy for the switch-on detection of HNE (59).
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Furthermore, with ﬂuorescently-labeled oligonucleotides,
it is always necessary to consider the effect of the ﬂuoro-
phore on the secondary structure of the aptamer and/or
the stability of the aptamer–protein complex. This factor
is not as important with the label-free methods since most
of the luminescent probes are able to bind to multiple
locations on the aptamer. However, drawbacks to
label-free method include a sometimes lower sensitivity
and a lack of multiplex detection capability.
In 2004, the group of Fang and Bai developed a
label-free detection method (61) for protein detection using
aptamers in conjunction with the ‘molecular light switch’
complex [Ru(phen)2(dppz)]
2+ (phen=1,10-phenan-
throline, dppz), dipyrido[3,2-a:20,30 c]phenazine) (62).
The ruthenium complex is only weakly emissive in aque-
ous solution due to the coordination of the phenazine
nitrogen with the water molecules, resulting lumines-
cent quenching of the triplet MLCT excited state through
non-radiative decay modes. Intercalation of the ruthenium
complex into the hydrophobic environment within the
DNA duplex protects the phenazine ligand from solvent
quenching, leading to an emission enhancement. The
phosphorescence emission of the ruthenium complex at
610 nm increased by 20-fold in the presence of the IgE
aptamer, which is predicted to form a hairpin conform-
ation in solution. However, upon addition of IgE, the sec-
ondary structure of the aptamer was disrupted, resulting
in a maximal luminescent decrease of 35% at a 14:8:1
ratio of protein:complex:aptamer. The response was linear
in the range of 0–0.8 nM, and a detection limit of 0.1 nM
was reported (61). The probe was also able to function
with the same performance in 1% serum compared to
physiological buffer. The presence of non-speciﬁc duplex
DNA could also be overcome by increasing the concen-
tration of the ruthenium complex to ensure saturation
of the intercalating dye into the aptamer. However, this
would likely decrease the dynamic range of the sys-
tem due to strong emission of the ruthenium complex
when bound to the non-speciﬁc DNA. In the same
work, similar label-free probes were developed for
PDGF-BB and thrombin. For PDGF-BB, the authors
employed the 35-nt three-way helix aptamer and
achieved a detection limit of 1.0 nM for PDGF in both
physiological buffer and 1% serum. A maximum decrease
of 30% was observed at the highest concentration of
PDGF tested. For thrombin detection, the authors inter-
estingly chose a hairpin RNA aptamer instead of the
DNA aptamers that have been described previously.
Presumably, the ruthenium complex may not have exhibited
strong binding to the well-known G15D thrombin
G-quadruplex aptamer. With the RNA aptamer, the lu-
minescence intensity of the probe decreased by 35% at
saturation, and a detection limit of 10 pM was reported.
This detection limit was superior to those achieved with
DNA aptamers, and represents the lowest detection limit
for thrombin using these methods reported to date. This
work by the group of Fang and Bai successfully
demonstrated the feasibility of using label-free detection
for DNA-binding proteins (61). However, the relatively
small dynamic range of the assay (35% maximal signal
decrease) and the switch-off mode of detection are the
drawbacks to this assay.
In 2006, the group of Li and Fang reported a modiﬁca-
tion of their earlier strategy by employing TOTO (63)
instead of a ruthenium light switch complex (64). TOTO
is an unsymmetrical cyanine dye that is non-ﬂuorescent in
solution but forms a highly ﬂuorescent complex with
DNA, with a 3000-fold increase in ﬂuorescence quantum
yield. Here, TOTO binds strongly to the PDGF-BB
aptamer 50-CAGGCTACGG CACGTAGAGCATCAC
CATGATCCTG-30 in the absence of the protein, and is
strongly ﬂuorescent. However, the PDGF was found to
decrease the ﬂuorescence emission intensity of TOTO, pre-
sumably due to the protein-induced conformational
change of the aptamer and the blocking of TOTO inter-
calation by the protein. The ﬂuorescence of TOTO
decreased by a maximum of 50% at a 20:6:1 ratio of pro-
tein: TOTO: aptamer, with a detection limit of 0.1 nM was
reported for this method. By comparison, the use of the
ruthenium complex [Ru(phen)2(dppz)]
2+ as the intercalat-
ing dye for this particular system gave inferior results. This
suggests that the response of the luminescent probes
towards target binding may be different for different
aptamer–protein complexes, and that a variety of lumines-
cent probes should be tested for each system to achieve the
best performance.
Dong and co-workers reported a more general method
for the label-free luminescent detection of thrombin that
does not rely on the nature of the target-induced conform-
ational rearrangement of the aptamer (65). Here, the 15-nt
thrombin aptamer 50-GGTTGGTGTGGTTGG-30 was
hybridized with its complementary sequence 50-CCAAC
CACACCAACC-30, allowing intercalation of the well-
known DNA-binding dye ethidium bromide (EB) (66)
and resulting in a strong ﬂuorescence signal. Thrombin
competes with the complementary strand for the aptamer
strand, leading to partial unwinding of the duplex and
shifting the equilibrium towards the aptamer-thrombin
complex (Figure 6). Since EB does not interact as well
with the released ss complementary sequence or the
aptamer G-quadruplex, a concentration-dependent reduc-
tion in the ﬂuorescence intensity of EB was observed as
the amount of thrombin added was increased. The titra-
tion results revealed a nearly linear response of the probe
to thrombin in the range 0–22.8 nM, and a detection limit
of 2.8 nM was reported (65). However, the maximum
decrease in the emission intensity at a saturating concen-
tration of thrombin was only 9%. This could be due to
the non-speciﬁc binding of EB to ssDNA and/or the
G-quadruplex, resulting in a lower sensitivity for the
assay. Using a more selective DNA-binding dye may
thus improve the performance of this probe for thrombin.
Mechanistically, this duplex-to-quadruplex conversion re-
sembles the thrombin molecular aptamer beacon previous-
ly described (47), except that in the present case, the
aptamer binding site is buried within a duplex arrange-
ment instead of mainly residing within the unhybridized
loop region of the aptamer beacon. As a consequence, the
aptamer binding sequence is less exposed to the target,
resulting in a longer incubation time (30min) required
for binding.
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METHODS FOR PROTEIN DETECTION BASED
ON EXONUCLEASE PROTECTION
DNase footprinting assays (6) tend to be unwieldy and
time-consuming, and necessitate stringent safety measures
to control radiographic exposure. Wang and co-workers
pioneered a new method for the detection of speciﬁc
DNA-binding proteins by combining the principles of
DNA footprinting with FRET detection (67). In this assay,
the FRET probe consists of two complementary DNA
oligonucleotides, one of which was labeled with a donor
ﬂuorochrome and the other with an acceptor, in the central
region of the oligomers (Figure 7). Flanking the donor–
acceptor pair are two identical complete protein-binding
sites. If the cognate protein is present, the formation of the
protein–DNA complex prevents the exonuclease III
(ExoIII)-mediated nucleolytic degradation of the probe,
and the FRET pair remains intact. In the absence of
protein, the digestion of the probe by ExoIII will release
the ﬂuorochromes as mononucleotides, resulting in a low
FRET signal. As a proof-of-concept, the complementary
oligonucleotides 50-AGTTGAGGGGACTTTCCCAACT
AGGAAFTCTACCTGGGGACTTTCCCAGGC-30
(F=dT-ﬂuorescein) and 30-TCAACTC CCCTGAAAG
GGTTGATCCTDAAGATGGACCCCTGAAAGGGT
CCG-50 (D=dT-dabcyl) containing the NF-kB (68–70)
consensus sequence GGGACTTTCC were prepared for
p50 transcription factor detection. The results revealed
that as the concentration of p50 protein was progressively
increased, the emission intensity of the ﬂuorescein at the
end of the digestion reaction was gradually reduced, due
to the protection of the FRET probe by the DNA-binding
protein which preserved the close proximity of the
ﬂuorophore to the quencher. While no detection limit
was reported by the authors, the 5 nM of p50 could be
readily detected using this probe (67). Similar FRET
probes were prepared for SP1 and p53. The authors
also applied the probe for the detection of NF-kB activity in
TNF-a-stimulated HeLa nuclear cell extracts. Furthermore,
multiplex protein detection was demonstrated using this
assay by utilizing ﬂuorophores with distinct excitation
and emission wavelengths (67). The chief advantage of
the exonuclease protection assay method for the detection
of DNA-binding proteins compared to the MB or aptamer
beacon methods described previously is that it is no longer
necessary to consider the equilibria between the multiple
conformations of the oligonucleotide and the bound and
free states of the beacon or aptamer. Thus, the present
method is generally applicable for the detection of proteins
with intrinsic DNA-binding activity. Note that there
should be sufﬁcient distance between the ﬂuorophore
pair and each of the protein binding sites, to avoid steric
hindrance to protein binding. Furthermore, the exonucle-
ase protection assay method may also be susceptible to
false positives arising from non-speciﬁc DNA binding.
A similar principle was employed by the group of
Levine and Mirkin to develop a variant of the exonuclease
protection assay termed ‘ﬂuorescence recovery’ (71). Here,
the ﬂuorophore (ﬂuorescein) and quencher (dabcyl) were
incorporated at the end of the duplex probe rather than in
the middle. Since ExoIII preferentially recognizes the free
30-hydroxyl on the double-stranded DNA and cleaves in
the 30 ! 50 direction, the digestion of the duplex can only
occur from one terminus since the other is blocked by the
ﬂuorescent dyes. Consequently, only one protein binding
site is required. In the absence of the protein, digestion of
the strand containing the ﬂuorophore proceeds freely,
releasing the ﬂuorophore from the quencher and resulting
in the recovery of ﬂuorescence. In the presence of the tar-
get, ExoIII digestion cannot proceed past the protein-
binding site, and the proximity of the ﬂuorophore pair is
preserved. To demonstrate this, a 26-bp Xenopus laevis
vitellogenin A2 ERE sequence 50-CAAAGTCAGGTCA
CAGTGACCTGATC-30 was labeled with ﬂuorescein at
the 50-end, while its complementary sequence 50-GATCA
GGTCACTGTGACCTGACTTTG-30 was labeled with
dabcyl at the 30-terminus. As the concentration of ER
was increased, the percentage of ﬂuorescence recovered
was reduced due to the protection of the DNA duplex
Figure 6. Schematic representation of the label-free aptamer strategy for the switch-off detection of thrombin via the target-induced conversion of
the duplex structure into a G-quadruplex (65).
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by the transcription factor. At a 2.6:1 ratio of protein to
DNA, only 42% of the emission of ﬂuorescein was re-
covered after incubation with ExoIII for 20min (71). The
authors demonstrated the multiplex detection capability of
the system by constructing distinct probes that contained
different ﬂuorophore–quencher pairs (such as ﬂuorescein–
dabcyl or Cy5–dabcyl). When the probes were incubated
in the same solution in the presence of ERa and ExoIII,
the ﬂuorescence recovery for the Vit ERE sequence (65%)
was lower than that for the VEGF sequence (90%), sug-
gesting that the transcription factor binds more strongly
to the ERE sequence than VEGF (71). This study demon-
strates that this system can be employed to determine the
relative binding afﬁnity of a transcription factor for a
variety of sequences in a multiplexed format.
In 2011, our research group reported a label-free vari-
ation of the ﬂuorescence recovery assay for the detection
of NF-kB p50 DNA-binding activity (72). Here, the ‘mo-
lecular light switch’ complex [Ru(phen)2(dppz)]
2+ was
used to discriminate between bound and unbound DNA
products resulting from exonuclease digestion. In the
absence of p50, the duplex probe becomes digested by
ExoIII. The ruthenium complex only interacts weakly
with the resulting ss fragments, and the ﬁnal phosphores-
cence intensity of the solution is low. The addition of p50
protects the probe from exonucleolytic cleavage, allowing
the intercalation of the metal complex and resulting in a
high luminescence signal (Figure 8). The results revealed
that the duplex substrate 50-TTGAGGGACTTTCCGAA
CATGCAGGCAAGCTGGGGACTTTCCAGG-30 con-
taining two binding sites exhibited the best performance,
with an 8-fold maximal luminescence increase at a 50:20:1
ratio of the ruthenium complex:protein:DNA after
incubation with ExoIII (72). Signiﬁcantly, this assay
produces a ‘switch-on’ response to the transcription
factor target, in contrast to the switch-off mode of detec-
tion reported for the previously described exonuclease
protection assays. A switch-on detection mode is generally
more desirable for analytical purposes as they are less sus-
ceptible to false positives arising from non-speciﬁc
quenching mechanisms from interfering species in the
sample matrix. In the presence of NF-kB inhibitor
Figure 7. Schematic representation of the exonuclease protection assay for the switch-off detection of transcription factors (67).
Figure 8. Schematic representation of the label-free exonuclease protec-
tion assay for NF-kB p50 using molecular light switch complex
[Ru(phen)2(dppz)]
2+.
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oridonin (73,74), a marked reduction in the luminescence
response of the probe was observed, indicating that this
assay may be used to screen for modulators of transcrip-
tion factor activity.
CONCLUSIONS AND OUTLOOK
Over the last 10 years, there have been tremendous strides
in the development of luminescent assays for the detection
of DNA-binding proteins. Early methods were based on
ﬂuorescence anistropy or rudimentary FRET methods
relying on the interaction between endogenous tryptophan
residues or ﬂuorescent labels in the protein with ﬂuores-
cent oligonucleotides. However, disadvantages of these
approaches include a strong dependence on molecular
size (for anistropy) and lack of generalizability of the
assay. The discovery of the MB strategy mitigated many
of these drawbacks as the conformational change of the
oligonucleotide upon target binding could be rationally
predicted. Thus, labeled probes could be engineered that
were able to respond to this structure-switching event with
a measurable luminescence response, based largely on
FRET principles. We have described here several appro-
aches that employ MBs for the detection of DNA binding
probes, including those based on the association of duplex
half-sites (30–32) or the disruption of the MB hairpin
structure by non-speciﬁc SSB (27,29). The most sensitive
MB in this class was that for prokaryotic SSB reported by
Tan and co-workers, which achieved a detection limit of
0.2 nM (27). Heyduk and Heyduk also demonstrated that
the use of a donor–acceptor combination for ratiometric
FRET detection could give a higher fold-change lumines-
cence response for the MB compared to the quenching
mode using a ﬂuorophore–donor pair (30). However,
these beacons were limited only to the detection of non-
speciﬁc DNA-binding proteins or those with endogenous
sequence-recognition capabilities. The discovery of
aptamers, which are the nucleic acid equivalents of pro-
teins that are obtained through the SELEX, has greatly
expanded the repertoire of possible proteins that can be
detected through this approach. Some of these molecular
aptamer beacons were based on the protein-induced con-
formational change of the aptamer resulting in the joining
or separation of ﬂuorophores in space, producing a
change in the ﬂuorescence signal. Others were based on
the displacement of a competitor strand from a DNA
duplex by the target. The advantage of the latter
approach is that the precise conformational change of
aptamer is irrelevant, allowing the probe design to be gene-
ralized for the detection of other DNA-binding proteins.
However, the drawback is that the partial blocking of the
protein binding site on the aptamer within a duplex envir-
onment necessitates an increased incubation time to allow
the equilibrium to gradually shift towards the dissociated
aptamer strand, which could then be progressively cap-
tured by the protein target (52,59). Both quenching and
ratiometric modes of detection have been utilized for the
molecular aptamer beacon approach. Furthermore, the
group of Turro and Tan showed that excimer emission
could be an excellent alternative to FRET probes due to
their longer ﬂuorescence lifetime compared to that of
background biological species, allowing the sensitive de-
tection of PDGF in biological ﬂuids using a pyrene-
labeled aptamer and employing time-resolved ﬂuorescence
(54). We also highlighted one example where the incorp-
oration of a ﬂuorescent nucleotide anolog into the
aptamer sequence could be used to produce a probe for
DNA-binding proteins exhibiting up to 30-fold increases
in emission intensity (58). The lowest detection limit in the
class of molecular aptamer beacons reported was the
three-component aptamer probe for human neutrophil
elastase reported by Yu and co-workers, which could
sense 47 pM of protein at a signal-to-noise cut-off ratio
of 3 (59). However, the expensive cost of ﬂuorescently-
labeled oligonucleotides has engendered the development
of label-free luminescence detection methods that are
more attractive from an economical standpoint for
high-throughput or low-cost applications. Based on the
selectivity of the external dyes for different nucleic acid
conformations, the target-induced structure switching of
the MB or aptamer beacon can be readily transduced into
a luminescence response. The dyes that have been used
for the luminescence detection of DNA-binding proteins
include both organic and inorganic molecules, such as
TOTO (64), EB (65) and the molecular light switch
complex [Ru(phen)2(dppz)]
2+ (61). However, a signiﬁ-
cant drawback to the label-free approach is the lack of
multiplex capability. The lowest detection limit for the
label-free method was 10 pM for thrombin using
[Ru(phen)2(dppz)]
2+ and the thrombin aptamer (61).
Finally, we described luminescence methods for the detec-
tion of DNA-binding proteins based on exonuclease pro-
tection. Here, the binding of the protein target to its
cognate sequence protects the DNA from degradation
by exonuclease III. Both labeled oligonucleotides (67,71)
and label-free approaches using [Ru(phen)2(dppz)]
2+ (72)
have been applied towards the luminescence exonuclease
protection assay for the detection of proteins. The advan-
tages and disadvantages of the different luminescent de-
tection methods reviewed in this work are summarized in
Table 1.
In our opinion, the outlook for the further development
of luminescent detection methods for DNA-binding
proteins is highly promising. The MB strategy should be
generally applicable to all transcription factors since these
proteins recognize speciﬁc DNA sequences in order to
regulate gene expression. Aptamers obtained through
SELEX have already been discovered for a whole host
of molecular entities such as amino acids, proteins, cofac-
tors and small molecules. Similar to antibodies, it should
be theoretically possible in principle to raise high-afﬁnity
aptamers to any protein target, which could allow these
aptamer-based methods to be applied to the detection of
proteins that have high diagnostic or therapeutic import-
ance, regardless of their intrinsic DNA-binding activity.
Methods based on exonuclease protection also offer new
possibilities for the design of novel luminescent detection
assays, as these do not rely on speciﬁc conformational
changes for the beacon or aptamer and thus can be
readily generalizable for the detection of any transcription
factor. Furthermore, the principles of the exonuclease
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protection assay can be adapted for the detection of any
enzyme with DNA-modulating activities (75,76).
In terms of the luminescent labels or dyes, there are
several potential areas of improvement. First, new ﬂuor-
escence labels are being developed all the time (77,78),
including new technologies such as quantum dots (79),
which may pave the way for improved detection
technologies that exhibit lower background signals and
higher dynamic ranges. Another exciting recent develop-
ment is the use of surface plasmon resonance (SPR)
technologies to analyze protein–DNA interactions,
which features an optical readout, high sensitivity,
semi-automated detection protocols and ability to deter-
mine binding rate constants and equilibrium constants.
For example, SPR has been used to analyze the interaction
between DNA and E. coli SSB (80), tobacco transcription
factor NtERF2 (81), methyl-CpG binding domain protein
(82), human ER (83), HIV-1 reverse transcriptase (84),
streptavidin (85), human IgE (86) and yeast transcription
factor Gal4 (87). The ultimate objective of luminescence
assays is to be able to image speciﬁc DNA–protein inter-
actions directly in living tissues. Imaging in the near
infra-red (NIR) range is a step towards that goal due to
lower scattering and absorption of NIR photons in the
tissue. Bogdanov and co-workers have recently developed
a FRET-based NIR probe for NF-kB detection. Using a
Cy5.5–Cy7 donor–acceptor pair, the authors were able to
detect nanomolar p50 by measuring the ratio of the ﬂuor-
escence emission intensities at 700 (donor) and 800
(acceptor) nm (88). However, it is likely that additional
modiﬁcations will also have to be made to the nucleic acid
probes to protect them from degradation by endogenous
nucleases in living tissue. For the label-free techniques for
the detection of DNA-binding proteins, all of the methods
described here have utilized an intercalating organic or
inorganic dye for signal generation. Potentially, the use
of a more selective DNA-binder with the ability to
interact speciﬁcally with a particular aptamer conform-
ation (for example, the thrombin aptamer
G-quadruplex) could give rise to new detection
methodologies with improved selectivity in the presence
of excess genomic DNA. The methods described in this
review have paved a ﬁrm foundation for the future devel-
opment of novel luminescent DNA-based sensors for the
detection of proteins. Issues of biostability and cellular
delivery will likely be of paramount importance for the
sensing of proteins in living cells or tissues. Given the tre-
mendous advances achieved in this ﬁeld over the last
decade, it is exciting to consider the realm of possibilities
as researchers take these developments to the next level.
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Table 1. Advantages and disadvantages of different luminescent detection methods for DNA-binding proteins
Methods Advantages Disadvantages
Fluorescence anistropy or
early FRET methods
Only one ﬂuorescent label on the DNA is required. Fluorescence polarization has a small dynamic range
and depends on the sizes of the DNA and protein
molecules.
FRET signal depends on the number and position of
endogenous ﬂuorescent residues.
Lack of generalizability.
MB strategy An increased dynamic range not limited to the size of
molecules or the number and position of
endogenous ﬂuorescent residues.
Can be adapted for sensing different DNA-binding
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